Immunodeficiencies Caused by Infectious Diseases

Veterinary Clinics of North America - Small Animal Practice

Volumn 40, Issue 3, 2010, Pages 409-423

  Sykes, Jane E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Anaplasma phagocytophilum; Distemper virus; Ehrlichia canis; Feline immunodeficiency virus; Feline leukemia virus; Parvovirus

Indexed keywords

CANINE DISTEMPER; CANINE EHRLICHIOSIS; CELLULAR IMMUNITY; CORONAVIRUS INFECTION; CRYPTOCOCCOSIS; FELINE IMMUNODEFICIENCY VIRUS; FELINE INFECTIOUS PERITONITIS; FELINE LEUKEMIA VIRUS; FELINE PANLEUKOPENIA VIRUS; HOST PATHOGEN INTERACTION; HUMAN GRANULOCYTIC ANAPLASMOSIS; HUMORAL IMMUNITY; IMMUNE DEFICIENCY; INFECTION; LEISHMANIASIS; NONHUMAN; OPPORTUNISTIC INFECTION; RETROVIRUS INFECTION; REVIEW; VIRUS VIRULENCE;

ANIMALS; BACTERIAL INFECTIONS; CAT DISEASES; CATS; DOG DISEASES; DOGS; IMMUNE TOLERANCE; PARASITIC DISEASES, ANIMAL; VIRUS DISEASES;

ANAPLASMA PHAGOCYTOPHILUM; ANIMALIA; CANINE DISTEMPER VIRUS; CANINE PARVOVIRUS 2; EHRLICHIA CANIS; FELINE IMMUNODEFICIENCY VIRUS; FELINE INFECTIOUS PERITONITIS VIRUS; FELINE LEUKEMIA VIRUS; MORBILLIVIRUS; PARVOVIRUS;

EID: 77952769490     PISSN: 01955616     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cvsm.2010.01.006     Document Type: Review

References (73)

1. Beineke A., Puff C., Seehusen F., et al. Pathogenesis and immunopathology of systemic and nervous canine distemper. Vet Immunol Immunopathol 2009, 127(1-2):1-18.
2. Von Messling V., Milosevic D., Cattaneo R. Tropism illuminated: lymphocyte-based pathways blazed by lethal morbillivirus through the host immune system. Proc Natl Acad Sci U S A 2004, 101(39):14216-14221.
3. Von Messling V., Svitek N., Cattaneo R. Receptor (SLAM [CD150]) recognition and the V protein sustain swift lymphocyte-based invasion of mucosal tissue and lymphatic organs by morbillivirus. J Virol 2006, 80(12):6084-6092.
4. Appel M.J., Shek W.R., Summers B.A. Lymphocyte-mediated immune cytotoxicity in dogs infected with virulent canine distemper virus. Infect Immun 1982, 37(2):592-600.
5. Iwatsuki K., Okita M., Ochikubo F., et al. Immunohistochemical analysis of the lymphoid organs of dogs naturally infected with canine distemper virus. J Comp Pathol 1995, 113(2):185-190.
6. Wünschmann A., Kremmer E., Baumgärtner W. Phenotypical characterization of T and B cell areas in lymphoid tissues of dogs with spontaneous distemper. Vet Immunol Immunopathol 2000, 73(1):83-98.
7. Baumgärtner W., Boyce R.W., Alldinger S., et al. Metaphyseal bone lesions in young dogs with systemic canine distemper virus infection. Vet Microbiol 1995, 44(2-4):201-209.
8. Kauffman C.A., Bergman A.G., O'Connor R.P. Distemper virus infection in ferrets: an animal model of measles-induced immunosuppression. Clin Exp Immunol 1982, 47(3):617-625.
9. Wenzlow N., Plattet P., Wittek R., et al. Immunohistochemical demonstration of the putative canine distemper virus receptor CD150 in dogs with and without distemper. Vet Pathol 2007, 44(6):943-948.
10. Schobesberger M., Summerfield A., Doherr M.G., et al. Canine distemper virus-induced depletion of uninfected lymphocytes is associated with apoptosis. Vet Immunol Immunopathol 2005, 104(1-2):33-44.
11. Kerdiles Y.M., Cherif B., Marie J.C., et al. Immunomodulatory properties of morbillivirus nucleoproteins. Viral Immunol 2006, 19(2):324-334.
12. Schneider-Schaulies J., Schneider-Schaulies S. Receptor interactions, tropism, and mechanisms involved in morbillivirus-induced immunomodulation. Adv Virus Res 2008, 71:173-205.
13. Ehrensperger F., Pospischil A. Dtsch Tierarztl Wochenschr 1989, 96(4):184-186. [in German].
14. Smith H.W., Buxton A. Incidence of salmonellae in feces of dogs suffering from distemper. Nature 1950, 166(4228):824.
15. Fawi M.T., Tag el Din M.H., el-Sanousi S.M. Canine distemper as a predisposing factor for Nocardia asteroides infection in the dog. Vet Rec 1971, 88(13):326-328.
16. Ribeiro M.G., Salerno T., Mattos-Guaraldi A.L., et al. Nocardiosis: an overview and additional report of 28 cases in cattle and dogs. Rev Inst Med Trop Sao Paulo 2008, 50(3):177-185.
17. Dyer N.W., Schamber G.J. Pneumocystosis associated with canine distemper virus infection in a mink. Can Vet J 1999, 40(8):577-578.
18. Lemberger K.Y., Gondim L.F., Pessier A.P., et al. Neospora caninum infection in a free-ranging raccoon (Procyon lotor) with concurrent canine distemper virus infection. J Parasitol 2005, 91(4):960-961.
19. Lamm C.G., Rezabek G.B. Parvovirus infection in domestic companion animals. Vet Clin North Am Small Anim Pract 2008, 38(4):837-850. viii-ix.
20. Hueffer K., Parrish C.R. Parvovirus host range, cell tropism and evolution. Curr Opin Microbiol 2003, 6(4):392-398.
21. Pollock R.V. Experimental canine parvovirus infection in dogs. Cornell Vet 1982, 72(2):103-119.
22. Krakowka S., Olsen R.G., Axthelm M.K., et al. Canine parvovirus infection potentiates canine distemper encephalitis attributable to modified live-virus vaccine. J Am Vet Med Assoc 1982, 180(2):137-139.
23. Carlson J.H., Scott F.W., Duncan J.R. Feline Panleukopenia. I. Pathogenesis in germfree and specific pathogen-free cats. Vet Pathol 1977, 14(1):79-88.
24. Mendoza R., Anderson M.M., Overbaugh J. A putative thiamine transport protein is a receptor for feline leukemia virus subgroup A. J Virol 2006, 80(7):3378-3385.
25. Anderson M.M., Lauring A.S., Robertson S. Feline Pit2 functions as a receptor for subgroup B feline leukemia viruses. J Virol 2001, 75(22):10563-10572.
26. Keel S.B., Doty R.T., Yang Z., et al. A heme export protein is required for red blood cell differentiation and iron homeostasis. Science 2008, 319(5864):825-828.
27. Anderson M.M., Lauring A.S., Burns C.C., et al. Identification of a cellular cofactor required for infection by feline leukemia virus. Science 2000, 287(5459):1828-1830.
28. Kipar A., Kremendahl J., Grant C.K., et al. Expression of viral proteins in feline leukemia virus-associated enteritis. Vet Pathol 2000, 37(2):129-136.
29. Good R.A., Ogasawara M., Liu W.T., et al. Immunosuppressive actions of retroviruses. Lymphology 1990, 23(2):56-59.
30. Cianciolo G.J., Copeland T.D., Oroszlan S., et al. Inhibition of lymphocyte proliferation by a synthetic peptide homologous to retroviral envelope proteins. Science 1985, 230(4724):453-455.
31. Mitani M., Cianciolo G.J., Snyderman R., et al. Suppressive effect on polyclonal B-cell activation of a synthetic peptide homologous to a transmembrane component of oncogenic retroviruses. Proc Natl Acad Sci U S A 1987, 84(1):237-240.
32. Haraguchi S., Good R.A., Day-Good N.K. A potent immunosuppressive retroviral peptide: cytokine patterns and signaling pathways. Immunol Res 2008, 41(1):46-55.
33. Cockerell G.L., Hoover E.A., Krakowka S., et al. Lymphocyte mitogen reactivity and enumeration of circulating B- and T-cells during feline leukemia virus infection in the cat. J Natl Cancer Inst 1976, 57(5):1095-1099.
34. Hebebrand L.C., Mathes L.E., Olsen R.G. Inhibition of concanavalin A stimulation of feline lymphocytes by inactivated feline leukemia virus. Cancer Res 1977, 37(12):4532-4533.
35. Mathes L.E., Olsen R.G., Hebebrand L.C., et al. Abrogation of lymphocyte blastogenesis by a feline leukaemia virus protein. Nature 1978, 274(5672):687-689.
36. Perryman L.E., Hoover E.A., Yohn D.S. Immunologic reactivity of the cat: immunosuppression in experimental feline leukemia. J Natl Cancer Inst 1972, 49(5):1357-1365.
37. Trainin Z., Wernicke D., Ungar-Waron H., et al. Suppression of the humoral antibody response in natural retrovirus infections. Science 1983, 220(4599):858-859.
38. Wernicke D., Trainin Z., Ungar-Waron H., et al. Humoral immune response of asymptomatic cats naturally infected with feline leukemia virus. J Virol 1986, 60(2):669-673.
39. Lafrado L.J., Olsen R.G. Demonstration of depressed polymorphonuclear leukocyte function in nonviremic FeLV-infected cats. Cancer Invest 1986, 4(4):297-300.
40. Hoffmann-Jagielska M., Winnicka A., Jagielski D., et al. Influence of naturally acquired feline leukemia virus (FeLV) infection on the phagocytic and respiratory burst activity of neutrophils and monocytes of peripheral blood. Pol J Vet Sci 2005, 8(2):93-97.
41. Wardini A.B., Guimarães-Costa A.B., Nascimento M.T., et al. Characterization of neutrophil extracellular traps in cats naturally infected with feline leukemia virus. J Gen Virol 2010, 91(Pt 1):259-264.
42. Sykes JE, Malik R. Cryptococcosis. In: Greene CE, editor. Infectious diseases of the dog and cat. 4th edition. St Louis (MO): Saunders Elsevier, in press.
43. de Parseval A., Chatterji U., Sun P., et al. Feline immunodeficiency virus targets activated CD4+ T cells by using CD134 as a binding receptor. Proc Natl Acad Sci U S A 2004, 101(35):13044-13049.
44. Shimojima M., Miyazawa T., Ikeda Y., et al. Use of CD134 as a primary receptor by the feline immunodeficiency virus. Science 2004, 303(5661):1192-1195.
45. Tompkins M.B., Tompkins W.A. Lentivirus-induced immune dysregulation. Vet Immunol Immunopathol 2008, 123(1-2):45-55.
46. Yamamoto J.K., Sparger E., Ho E.W., et al. Pathogenesis of experimentally induced feline immunodeficiency virus infection in cats. Am J Vet Res 1988, 49(8):1246-1258.
47. Sprague W.S., Terwee J.A., Vandewoude S. Temporal association of large granular lymphocytosis, neutropenia, proviral load, and FasL mRNA in cats with acute feline immunodeficiency virus infection. Vet Immunol Immunopathol 2010, 134(1-2):115-121.
48. Mexas A.M., Fogle J.E., Tompkins W.A., et al. CD4+CD25+ regulatory T cells are infected and activated during acute FIV infection. Vet Immunol Immunopathol 2008, 126(3-4):263-272.
49. Vahlenkamp T.W., Tompkins M.B., Tompkins W.A. Feline immunodeficiency virus infection phenotypically and functionally activates immunosuppressive CD4+CD25+ T regulatory cells. J Immunol 2004, 172(8):4752-4761.
50. Dean G.A., LaVoy A., Yearley J., et al. Cytokine modulation of the innate immune response in feline immunodeficiency virus-infected cats. J Infect Dis 2006, 193(11):1520-1527.
51. Lehman T.L., O'Halloran K.P., Hoover E.A., et al. Utilizing the FIV model to understand dendritic cell dysfunction and the potential role of dendritic cell immunization in HIV infection. Vet Immunol Immunopathol 2010, 134(1-2):75-81.
52. Levy J.K., Liang Y., Ritchey J.W., et al. Failure of FIV-infected cats to control Toxoplasma gondii correlates with reduced IL2, IL6, and IL12 and elevated IL10 expression by lymph node T cells. Vet Immunol Immunopathol 2004, 98(1-2):101-111.
53. de Groot-Mijnes J.D., van Dun J.M., van der Most R.G., et al. Natural history of a recurrent feline coronavirus infection and the role of cellular immunity in survival and disease. J Virol 2005, 79(2):1036-1044.
54. Weinman D. Human bartonella infection and African sleeping sickness. Bull N Y Acad Med 1946, 22(12):647-670.
55. Pappalado B.L., Brown T., Gebhardt D., et al. Cyclic CD8+ lymphopenia in dogs infected with Bartonella vinsonii subspecies berkhoffii. Vet Immunol Immunopathol 2000, 75(1-2):43-57.
56. Baker H.J., Cassell G.H., Lindsey J.R. Research complications due to Haemobartonella and Eperythrozoon infections in experimental animals. Am J Pathol 1971, 64(3):625-632.
57. Philbey A.W., Barron R.C., Gounden A. Chronic eperythrozoonosis in an adult ewe. Vet Rec 2006, 158:662-664.
58. Breitschwerdt E.B., Woody B.J., Zerbe C.A., et al. Monoclonal gammopathy associated with naturally occurring canine ehrlichiosis. J Vet Intern Med 1987, 1(1):2-9.
59. Schroeder H., Jardine J.E., Davis V. Systemic phaeohyphomycosis caused by Xylohypha bantiana in a dog. J S Afr Vet Assoc 1994, 65(4):175-178.
60. Mekuzas Y., Gradoni L., Oliva G., et al. Ehrlichia canis and Leishmania infantum co-infection: a 3-year longitudinal study in naturally exposed dogs. Clin Microbiol Infect 2009, [Epub ahead of print].
61. Harrus S., Waner T., Friedmann-Morvinski D., et al. Down-regulation of MHC class II receptors of DH82 cells, following infection with Ehrlichia canis. Vet Immunol Immunopathol 2003, 96(3-4):239-243.
62. Hess P.R., English R.V., Hegarty B.C., et al. Experimental Ehrlichia canis infection in the dog does not cause immunosuppression. Vet Immunol Immunopathol 2006, 109(1-2):117-125.
63. Carrade D.D., Foley J.E., Borjesson D.L., et al. Canine granulocytic anaplasmosis - a review. J Vet Intern Med 2009, 23(6):1129-1141.
64. Rikihisa Y. Ehrlichia subversion of host innate responses. Curr Opin Microbiol 2006, 9:95-101.
65. Carlyon J.A., Fikrig E. Mechanism of evasion of neutrophil killing by Anaplasma phagocytophilum. Curr Opin Hematol 2006, 13:28-33.
66. Garyu J.W., Choi K.S., Grab D.J., et al. Defective phagocytosis in Anaplasma phagocytophilum infected neutrophils. Infect Immun 2005, 73:1187-1190.
67. Choi K.S., Garyu J., Park J., et al. Diminished adhesion of Anaplasma phagocytophilum-infected neutrophils to endothelial cells is associated with reduced expression of leukocyte surface selectin. Infect Immun 2003, 71:4586-4594.
68. Nyarko E., Grab D.J., Dumler J.S. Anaplasma phagocytophilum-infected neutrophils enhance transmigration of Borrelia burgdorferi across the human blood brain barrier in vitro. Int J Parasitol 2006, 36:601-605.
69. Foglia Manzillo V., Pagano A., Guglielmino R., et al. Extranodal gammadelta-T-cell lymphoma in a dog with leishmaniasis. Vet Clin Pathol 2008, 37(3):298-301.
70. Zambrano-Villa S., Rosales-Borjas D., Carrero J.C., et al. How protozoan parasites evade the host immune response. Trends Parasitol 2002, 18(6):272-278.
71. Lieke T., Nylén S., Eidsmo L., et al. Leishmania surface protein gp63 binds directly to human natural killer cells and inhibits proliferation. Clin Exp Immunol 2008, 153(2):221-230.
72. Yauch L.E., Lam J.S., Levitz S.M. Direct inhibition of T-cell responses by the Cryptococcus capsular polysaccharide glucuronoxylomannan. PLoS Pathog 2006, 2(11):e120.
73. Osterholzer J.J., Surana R., Milam J.E., et al. Cryptococcal urease promotes the accumulation of immature dendritic cells and a non-protective T2 immune response within the lung. Am J Pathol 2009, 174(3):932-943.